• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hypercalcemia in Children Following a Discontinuation of Denosumab Therapy: A Case Report and Literature Review.

作者信息

Liu Xu, Xie Yanshu, Tang Jing, Zhong Jingzi, Lan Dan

机构信息

Department of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

出版信息

Clin Pediatr (Phila). 2024 Jun;63(6):750-754. doi: 10.1177/00099228231194427. Epub 2023 Aug 18.

DOI:10.1177/00099228231194427
PMID:37594083
Abstract
摘要

相似文献

1
Hypercalcemia in Children Following a Discontinuation of Denosumab Therapy: A Case Report and Literature Review.狄诺塞麦治疗中断后儿童高钙血症：一例报告及文献综述
Clin Pediatr (Phila). 2024 Jun;63(6):750-754. doi: 10.1177/00099228231194427. Epub 2023 Aug 18.
2
Severe hypercalcemia following denosumab treatment in a juvenile patient.一名青少年患者在接受地诺单抗治疗后出现严重高钙血症。
J Bone Miner Metab. 2016 Jan;34(1):118-22. doi: 10.1007/s00774-015-0677-z. Epub 2015 Jun 9.
3
Hypercalcemia upon denosumab withdrawal in primary hyperparathyroidism: a case report and literature review.原发性甲状旁腺功能亢进症停用地舒单抗后发生高钙血症：病例报告及文献复习。
Osteoporos Int. 2020 Dec;31(12):2485-2491. doi: 10.1007/s00198-020-05676-7. Epub 2020 Oct 15.
4
Hypercalcemia and hypercalciuria during denosumab treatment in children with osteogenesis imperfecta type VI.VI型成骨不全患儿在狄诺塞麦治疗期间的高钙血症和高钙尿症。
J Musculoskelet Neuronal Interact. 2018 Mar 1;18(1):76-80.
5
Hypercalcemia after discontinuation of long-term denosumab treatment.长期地诺单抗治疗停药后的高钙血症
Osteoporos Int. 2016 Jul;27(7):2383-2386. doi: 10.1007/s00198-016-3535-5. Epub 2016 Apr 20.
6
Effects and management of denosumab discontinuation.地诺单抗停药的影响及管理
Joint Bone Spine. 2018 Oct;85(5):515-517. doi: 10.1016/j.jbspin.2017.12.013. Epub 2018 Jan 6.
7
Stopping Denosumab.停止地舒单抗治疗。
Curr Osteoporos Rep. 2019 Feb;17(1):8-15. doi: 10.1007/s11914-019-00502-4.
8
[Treatment of osteoporosis with denosumab: it is necessary to anticipate its eventual discontinuation].用狄诺塞麦治疗骨质疏松症：有必要预期其最终停药情况
Rev Prat. 2019 Jun;69(6):592-594.
9
Denosumab for immobilization-induced hypercalcemia in patients with end-stage renal disease.地诺单抗用于治疗终末期肾病患者制动引起的高钙血症。
Clin Nephrol. 2024 Oct;102(4):254-256. doi: 10.5414/CN111361.
10
Letter to the Editor From Bala and Dayal: "Safety and Efficacy of Denosumab in Children With Osteogenesis Imperfecta-The First Prospective Comparative Study".
J Clin Endocrinol Metab. 2024 Sep 16;109(10):e1971-e1972. doi: 10.1210/clinem/dgae305.

引用本文的文献

1
Case report of hypercalcemia-related kidney complications after discontinuation of denosumab.停用地诺单抗后高钙血症相关肾脏并发症的病例报告
Front Pediatr. 2025 Jun 6;13:1583240. doi: 10.3389/fped.2025.1583240. eCollection 2025.
2
Early and multiple doses of zoledronate mitigates rebound bone loss following withdrawal of receptor activator of nuclear factor kappa-B ligand inhibition.早期多次给予唑来膦酸盐可减轻核因子κB受体活化因子配体抑制作用撤除后的骨质流失反弹。
J Bone Miner Res. 2025 Mar 15;40(3):413-427. doi: 10.1093/jbmr/zjaf008.
3
Central giant cell granuloma of the jaws-long-term clinical and radiological outcomes of surgical and pharmacological management.
颌骨中央性巨型细胞瘤——手术和药物治疗的长期临床和放射学结果。
Clin Oral Investig. 2024 Mar 7;28(3):200. doi: 10.1007/s00784-024-05585-7.